Quick Takeaways
- Kenneth Bate has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,295,433.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Kenneth Bate
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Kenneth Bate is at least $1,295,433 dollars as of 23 Jan 2026. Kenneth Bate is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.29M. Kenneth Bate is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.6K.
- Signature
- /s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kenneth Bate and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: MADRIGAL PHARMACEUTICALS, INC. ($1,289,808).
- Past-year value change for that position: -$11,679,363.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Kenneth Bate
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | $1,289,808 | -$11,679,363 | -90% | 05 Nov 2025 |
| AVEO | AVEO PHARMACEUTICALS, INC. | Director | $5,625 | 19 Jan 2023 | ||
| ATXS | Astria Therapeutics, Inc. | Director | 23 Jan 2026 | |||
| EPZM | Epizyme, Inc. | Director | 12 Aug 2022 | |||
| GNCA | GENOCEA BIOSCIENCES, INC. | Director | 01 Jul 2021 |
Insider Transactions Reported by Kenneth Bate:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.